Systematic literature review to identify cost estimates of liver disease in those with chronic hepatitis C virus (Hcv) in the United States
The objective of the review was to determine the most widely used estimates of United States (US) costs of different stages of liver disease in patients with hepatitis C virus (HCV) in cost-effectiveness analyses (CEA).
Citation
Mauskopf, J., Mitchell, S., Samuel, M., & Samp, JC. (2015). Systematic literature review to identify cost estimates of liver disease in those with chronic hepatitis C virus (Hcv) in the United States. Value in Health, 18(3), A236. DOI: 10.1016/j.jval.2015.03.1374
